Drug · DIN 02530171
TRULICITY
0.5 ML SINGLE-USE PREFILLED PEN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since August 25, 2022.
- Drug Identification Number (DIN)
- 02530171
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Dulaglutide A10BJ05
- Class
- Human
- Record last updated
- August 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DULAGLUTIDE | 4.5 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 25, 2022: NOC 28823Supplement to a New Drug Submission (SNDS) · New strengths
Other DINs named TRULICITY
- DIN 02448599 · Marketed
- DIN 02448602 · Marketed
- DIN 02448572 · Cancelled Pre Market
- DIN 02448580 · Cancelled Pre Market
- DIN 02530163 · Approved